Search research articles
Contact Us
Filters
Showing results (251-260 of 259) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 259 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2019
Prevalence of and Risk Factors for Anal High-grade Squamous Intraepithelial Lesions in Women Living with Human Immunodeficiency Virus
Elizabeth A Stier, Shelly Y Lensing, Teresa M Darragh, et al.
AIDS (London, England)
|
September 18, 2020
Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV
Elizabeth Y Chiao, Shelly Y Lensing, Dorothy J Wiley, et al.
AIDS and Behavior
|
October 17, 2021
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
José A Bauermeister, Ryan C Tingler, Clara Dominguez, et al.
AIDS Research and Human Retroviruses
|
September 9, 2021
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
Ross D Cranston, Elizabeth Brown, José Bauermeister, et al.
Chemical Society Reviews
|
April 17, 2018
Current characterization methods for cellulose nanomaterials
E Johan Foster, Robert J Moon, Umesh P Agarwal, et al.
Plos One
|
July 28, 2017
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
Alex Carballo-Diéguez, Ivan C Balán, William Brown, et al.
Microbiology Spectrum
|
March 23, 2026
Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways
Sean M Hughes, Fernanda L Calienes, Claire N Levy, et al.
Cell Reports. Medicine
|
October 5, 2020
Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection
Sean M Hughes, Claire N Levy, Fernanda L Calienes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel
Ross D Cranston, Javier R Lama, Barbra A Richardson, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 259) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 259 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2019
Prevalence of and Risk Factors for Anal High-grade Squamous Intraepithelial Lesions in Women Living with Human Immunodeficiency Virus
Elizabeth A Stier, Shelly Y Lensing, Teresa M Darragh, et al.
AIDS (London, England)
|
September 18, 2020
Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV
Elizabeth Y Chiao, Shelly Y Lensing, Dorothy J Wiley, et al.
AIDS and Behavior
|
October 17, 2021
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
José A Bauermeister, Ryan C Tingler, Clara Dominguez, et al.
AIDS Research and Human Retroviruses
|
September 9, 2021
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
Ross D Cranston, Elizabeth Brown, José Bauermeister, et al.
Chemical Society Reviews
|
April 17, 2018
Current characterization methods for cellulose nanomaterials
E Johan Foster, Robert J Moon, Umesh P Agarwal, et al.
Plos One
|
July 28, 2017
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
Alex Carballo-Diéguez, Ivan C Balán, William Brown, et al.
Microbiology Spectrum
|
March 23, 2026
Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways
Sean M Hughes, Fernanda L Calienes, Claire N Levy, et al.
Cell Reports. Medicine
|
October 5, 2020
Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection
Sean M Hughes, Claire N Levy, Fernanda L Calienes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel
Ross D Cranston, Javier R Lama, Barbra A Richardson, et al.
Page
of 26